drugset / Trial / NCT00416845

Effects of FTY720 on Heart and Lung Functions in Healthy Volunteers

NCT00416845

Phase 1 Completed 39 enrolled Novartis
RandomizedParallel-groupDouble-blindTreatment

Summary

This study is designed to assess the effects of two doses of FTY720 on lung (pulmonary) and cardiac (heart) functions in healthy volunteers.

Timeline

Start
2006-10
Primary completion
2007-03
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Fingolimod Small molecule 0.5 mg
Subject Fingolimod Small molecule 1.25 mg

Indications

No indication recorded.